People with CTEPH and higher PAWP may see fewer gains from BPA, though safety and survival remain similar, a study shows.

People with CTEPH and higher PAWP may see fewer gains from BPA, though safety and survival remain similar, a study shows.

Guideline-recommended therapies for heart failure (HF) were found to be ineffective in patients with HF caused by Chagas ...

The effective use of electronic patient records (EPR), in secondary care, to deliver clinical workflows represents a ...

India: A new retrospective study from Father Muller Medical College, Mangalore, has highlighted the critical role of ...

Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...

Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in ...

GLP-1s are linked to an increase in heart rate and number of ventricular events in patients with heart failure with reduced ejection fraction and implanted cardiac devices.

As Hungary’s healthcare system continues its journey of integration and modernization, the role of high-quality, timely ...

Researchers are developing non-invasive saliva tests to detect heart failure early, potentially before symptoms appear. Studies have identified key salivary biomarkers, and a prototype device, eCaDI, ...

The ATTRibute-CM study's open-label extension showed that acoramidis effectively lowers all-cause mortality in patients with ...

Cardiovascular disease (CVD) is the leading cause of death worldwide, accounting for approximately 30% of global mortality and imposing a substantial economic burden on society. Due to the high ...